Statement by Stanford President John Hennessy on Jim Clark`s stem cell announcement

Today, Aug.31, Jim Clark has announced that he will suspend payment on $60 million of his $150 million pledge to create a center for biomedical science and engineering research at Stanford. The suspension of his pledge is to protest evolving federal policies and restrictions on stem cell research and potentially on non-reproductive cloning. While we are saddened by Mr. Clark`s decision, we are deeply grateful for the $90 million he already has committed to The James H. Clark Center for Biomedical Engineering and Sciences, and we appreciate his strong feelings on this subject.

The Clark Center is at the core of a broad-based interdisciplinary initiative at Stanford, called Bio-X. Bio-X will bring together researchers from the biosciences, physical sciences and engineering to focus on interdisciplinary biomedical research. The past two years have seen tremendous growth in the Bio-X program. Construction of the 225,000-square-foot Clark Center is underway. When occupied in 2003, the center will accommodate about 50 faculty from a wide range of disciplines. Mr. Clark`s initial $90 million gift will allow us to continue to build this vital center and accelerate important interdisciplinary research at Stanford.

Most of the activities planned for Bio-X and the Clark Center will be unaffected by the recent federal decisions. As Channing Robertson, co-director of Bio-X and Professor of Chemical Engineering, points out, stem cell research is only one component of a much broader vision for the program. ``The Bio-X executive committee is considering a number of research areas: molecular biophysics, proteomics, genomics, microbial biology, complex systems and neurosciences, biocomputation, biodesign, robotics, and molecular and cellular imaging,`` he reports.

Paul Berg, a professor emeritus in the Department of Biochemistry and winner of the 1980 Nobel Prize in chemistry for his pioneering work with recombinant DNA, observed that ``Stanford`s efforts in

Contact: Elaine Ray
Stanford University

Page: 1 2

Related biology news :

1. Statement by the Ethics Advisory Board of Advanced Cell Technology, Inc.
2. Statement from Dr. Claude Lenfant on discovery of the gene for primary pulmonary hypertension
3. Statement by APA President Allan Tasman, M.D., on the Surgeon Generals Report on Mental Health
4. Statement on discovery of the gene for narcolepsy in dogs
5. Statement Of The DFG Concerning "Questions Of Human Embryonic Stem Cells"
6. AHA Issues Scientific Statement On Infective Endocarditis
7. Environmental Impact Statements Need To Be Made Easier To Decipher
8. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
9. Stanford researchers findings may shed light on common, deadly birth defect
10. Leukemia stem cells identified by Stanford researchers
11. New view of leukemia cells identifies best treatment options, Stanford researchers say

Post Your Comments:

(Date:6/5/2020)... ... ... “Although we are disappointed to have to make this decision our primary ... We remain committed to creating a global platform to showcase the science, and ... of WMIS. , The abstract deadline for the virtual meeting is ...
(Date:6/2/2020)... ... June 02, 2020 , ... ... barcode and RFID labeling software developer and solutions provider, today reported that ... improved labeling accuracy and compliance by 100%, resulting in greater efficiency for ...
(Date:5/28/2020)... (PRWEB) , ... May 27, 2020 , ... CrucialTrak, a ... partner with New Jersey-based Critical Environments Group (CEG) to market and sell its complete ... of data center and IT environment infrastructure optimization solutions . , Brett ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... ... (PTU) is commonly used to suppress pigment formation in zebrafish embryos, maintaining optical ... team led by Dr MA has been using the zebrafish model to investigate ...
(Date:7/7/2020)... ... 06, 2020 , ... R3 International is now offering stem cell therapy for ... cells. Depending on the patient's condition, treatment may be offered IV, intrathecal or with ... form of Alzheimers dementia, and the incidence continues to increase as individuals live longer. ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... growth of 40% in 2020, despite many obstacles created as a result of ... increase revenue for its partnered medical practices and medical manufacturers by expanding access ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... launch of a new clinical diagnostics immuno-oncology service, TissueInsight . TissueInsight ... , “Flagship’s TissueInsight is a service that aids pathologists, oncologists, and immunologists ...
Breaking Biology Technology:
Cached News: